Alebund Pharmaceuticals (jiangsu) Limited Class H (9637) Press Release
PHIP (1st submission)
Filed with HKEX ·
On 6ix: 6ix.com/news/phip-1st-submission
6ix hasn’t read this filing yet.
Alebund Pharmaceuticals (Jiangsu) Limited on 6ix
Later from Alebund Pharmaceuticals (Jiangsu)
- Documents on Display
- List of directors and their roles and functions
- Announcement of final offer price and allotment results
- Alebund's AP301 NDA Accepted for Review by China's NMPA
- 2026 Interim report
Follow Alebund Pharmaceuticals (Jiangsu) into a list and get an email when it puts out news.
Follow Alebund Pharmaceuticals (Jiangsu)